Find and Pitch Jounalists, Get Your Story Covered

Tags: apps instagram Meta service outage multiple sclerosis

	Profile	Recent Articles on Subject
1	Greg Laub MedPage Today Director of Video at MedPage Today. Screenwriter, previous managing editor. videographyscreenwritingediting	Inebilizumab for Myasthenia Gravis Reduces Steroid Burden - 11 days ago Developing a Consensus on Smoldering MS - 12 months ago High NfL Levels Predict Greater MS Disability Within 2 Years - 12 months ago A Novel Mechanism of Action in Treating Relapsing MS - about 1 year ago New Data on CD40 Ligand Inhibitor for Relapsing MS - about 1 year ago Should MS Patients Stop Treatment as They Age? - about 1 year ago Targeting Chronic Inflammation in Progressive MS - about 1 year ago Multiple Sclerosis: Treat Early With High-Efficacy Therapy - about 1 year ago Should the Way We Describe MS Progression Change? - about 1 year ago Central Vein Sign as an Imaging Biomarker of Multiple Sclerosis - about 1 year ago Multiple Sclerosis: Paving the Way to a Cure - about 1 year ago MS Treatment-Discontinuation Study Terminated After Disease Activity Returns - about 1 year ago Emerging Biomarkers of Multiple Sclerosis in Blood and CSF - about 1 year ago
2	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment	FDA Approves Ocrevus Zunovo for 2 Forms of Multiple Sclerosis - 2 months ago
3	Jonathan Wosen STAT News West Coast Biotech Reporter. Formerly @sdut. Stanford PhD. UCSC alum. San Diego, California BiotechLife SciencesImmunology	STAT+: FDA approves Roche’s injectable version of blockbuster multiple sclerosis drug - 2 months ago
4	Sophie Putka MedPage Today Enterprise, investigative writer. New York, USA enterprise journalisminvestigative journalism	A Miss for Steroid-Toting Red Blood Cells in Ataxia Telangiectasia - 3 months ago Obesity Associated With Faster MS Disease Progression - 9 months ago Highly Effective Therapies Early in Pediatric MS Linked to Reduced Relapse Risk - 9 months ago Neurologic Disabilities Linked to Long COVID Risks - 11 months ago Progression Independent of Relapse Activity in Pediatric-Onset MS - 12 months ago
5	Amy Baxter Pharma Voice Scientist, inventor, former pediatrician. Atlanta, Georgia pain relieftechnologyinnovation	A potential MS ‘game changer’ could bring more safety to the table — even against viruses - 3 months ago
6	Judy George MedPage Today Medical reporter, writer. Medical reportingartsliterature	Vitamin D-MS Link; Nootropic Gummies Laced With Psilocybin; Forecasting Seizures - 4 months ago Epstein-Barr and MS; When Lewy Pathology Starts; Alzheimer's Blood Test Assessed - 8 months ago Cognitive Decline in MS Predicted by Paramagnetic Rim Lesions - 9 months ago Brain Dysfunction, Immune Abnormalities Seen in Post-Infectious Chronic Fatigue - 9 months ago Midlife Alzheimer's Biomarker; How Measles Spread in the Brain; MS and HIV - 11 months ago Twins and Dementia; CRISPR and Alzheimer's; BTK Inhibitor Fails in MS Trials - 11 months ago This Many U.S. Adults Have Chronic Fatigue Syndrome - 12 months ago Advanced Parkinson's Patient Regains Ability to Walk Confidently - about 1 year ago S1P Receptor Modulator May Boost Cognitive Processing Speed in Early MS - about 1 year ago BTK Inhibitor Reduces Brain Lesions in Relapsing MS - about 1 year ago Neurofilament Light Predicts MS Worsening in Silent Progression - about 1 year ago Acrylic Window to the Brain; Chronic Fatigue Discovery; AI Spots Parkinson's Risk - about 1 year ago
7	The Conversation Science Alert Science news. Official account. Australia science news	This New Blood Test Could Help Solve The Mystery of Multiple Sclerosis - 6 months ago Major Study Finds HIV Drugs Could Lower Risk of Multiple Sclerosis by Up to 72% - 11 months ago First-of-Its-Kind Trial Gives New Hope For Treating Multiple Sclerosis - 12 months ago
8	Isabella Cueto STAT News Journalist on chronic disease. healthjournalism	Multiple sclerosis has distinct subtypes, study finds, pointing to different treatments - 8 months ago NIH study of ME/CFS points to immune dysfunction and brain abnormalities at core of long-dismissed disease - 9 months ago A medical student was isolated by an autoimmune disorder. Poetry was a way out - 11 months ago
9	Kennedy Ferruggia, Assistant Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	FDA Approves Ravulizumab-cwvz for Neuromyelitis Optica Spectrum Disorder - 8 months ago FDA Grants Breakthrough Device Designation for Neuroimmune Modulation Platform To Treat MS - 8 months ago
10	Ed Susman MedPage Today Freelance Medical journalist. Owns medical site. West Palm Beach, Florida medical journalismwritinghealthcare	Long COVID May Be Difficult to Identify in MS - 9 months ago Rozanolixizumab Maintains Efficacy Among Generalized Myasthenia Gravis Subgroups - about 1 year ago

Journalists covering multiple sclerosis